QDQingyang Dong

Qingyang Dong

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Qingyang Dong has a total of 29 co-authors. Here are the top co-authors by number of shared publications:

  • Ying Liu

    Military Medical Sciences Academy, Academy of Military Sciences, Tianjin, China

    4 shared publications
  • Pengcheng Zhang

    Military Medical Sciences Academy, Academy of Military Sciences, Tianjin, China

    3 shared publications
  • Danyang Meng

    School of Basic Medicine, Jiamusi University, Jiamusi, Heilongjiang, China

    2 shared publications
  • Hua Li

    Tianjin Medical University Cancer Institute and Hospital

    2 shared publications
  • Jinhao Wang

    Military Medical Sciences Academy, Academy of Military Sciences, Tianjin, China

    2 shared publications
  • Lianqun Du

    Military Medical Sciences Academy, Academy of Military Sciences, Tianjin, China

    2 shared publications

Latest Publications

  • Open Access

    PD-L1 in plasmacytoid dendritic cells promote HBV persistence through disrupting humoral immune response

    by Danyang Meng, Jinhao Wang, Lianqun Du, Xiaojun Hu, Ying Liu, Pengcheng Zhang, Jianjie Wang, Qingyang Dong

    Objective: To investigate the efficacy of PD-L1 blockade in restoring humoral immune response against HBV.Methods: HBV‐persistent C57BL/6J mice were established through hydrodynamic tail vein injection of 10 µg pAAV‐HBV1.2 plasmid. Subsequently, mice treated i.p. with anti‐PD‐L1 and/or anti‐CTLA‐4 at specified time points, with dosages of 500 µg, 250 µg, and 250 µg, respectively. Additionally, 5 × 105 magnetic bead‐purified plasmacytoid dendritic cells (pDCs) were adoptively transferred i.v. into the acute mouse model followed by anti-PD-L1 treatment. Quantitative real-time PCR was employed to assess the expression levels of costimulatory and tolerogenic molecules in two dendritic cell subsets. Serum HBsAg and HBsAb were measured using ELISA. Flow cytometry was utilized to quantify T follicular helper (Tfh) cells, regulatory T cells (Treg), and germinal center (GC) B cells.Results: PD-L1 blockade markedly enhanced the differentiation of Tfh cells and GC B cells in HBV-persistent C57BL/6J mice, thereby promoting HBV clearance. Additionally, pDCs exhibited an increased capacity to induce immune tolerance, with pDCs isolated from HBV carriers inducing viral persistence. This persistence was effectively counteracted by treatment with anti-PD-L1.Conclusion: pDCs mediate the dysregulation of the humoral immune response to HBV through PD-L1 in chronic hepatitis B infection, highlighting a promising target for the management of chronic HBV.


  • Open Access

    Application of therapeutical nanoparticles with neutrophil membrane camouflaging for inflammatory plaques targeting against atherosclerosis

    by Ningnannan Zhang, Tianzhu Zhang, Jintang Feng, Jian Shang, Beibei Zhang, Qingyang Dong, Zhang Zhang, Chunyang Sun


  • P4HA3 promotes head and neck squamous cell carcinoma progression via the WNT/β-catenin signaling pathway

    by Quannian Wang, Danyang Meng, Si Shen, Yang Cao, Pengcheng Zhang, Ying Liu, Lianqun Du, Hua Li, Changli Shao, Qingyang Dong


  • Open Access

    Paeoniflorin alleviates oxidative stress and apoptosis in heat stress-induced H9c2 cells

    by Meng Wang, Ying Liu, Hua Li, Hui Liu, Xinxing Wang, Qingyang Dong

    Purpose: The increasing annual mean temperature has exacerbated the severity of heat stress (HS) which could increase cardiac burden. Paeoniflorin (PF), the primary bioactive constituent extracted from the Paeonifloraceae, exhibits robust antioxidant properties. However, its protective potential against HS-induced cardiomyocyte injury remains unclear. This study aimed to investigate the protective effects of PF on H9c2 cells subjected to HS-induced injury and elucidate the underlying mechanisms. Methods: To establish the heat stress model, H9c2 cells were exposed to HS for 2 h at 45 °C in a 5% CO2 incubator. Before HS exposure, H9c2 cells were pretreated with PF (5 µM) for 24 h. Subsequently, we assessed cell viability, oxidative stress, cardiomyocyte apoptosis, and mitochondrial function. Results: HS treatment significantly increased oxidative stress and apoptosis in H9c2 cells. However, pretreatment with PF for 24 h attenuated the HS-induced damage in H9c2 cells, protecting against thermal injury. Conclusion: Current studies have not investigated the role of PF on oxidative damage and apoptosis in vitro after HS. Our experiment demonstrated that PF ameliorates HS-induced oxidative stress and apoptosis in H9c2 cells which suggest that PF can potentially be an effective preventive medicine against heat injury to cardiomyocyte.

  • MSI-XGNN: an explainable GNN computational framework integrating transcription- and methylation-level biomarkers for microsatellite instability detection

    by Yang Cao, Dan Wang, Jin Wu, Zhanxin Yao, Si Shen, Chao Niu, Ying Liu, Pengcheng Zhang, Quannian Wang, Jinhao Wang, et al.

    Microsatellite instability (MSI) is a hypermutator phenotype caused by DNA mismatch repair deficiency. MSI has been reported in various human cancers, particularly colorectal, gastric and endometrial cancers. MSI is a promising biomarker for cancer prognosis and immune checkpoint blockade immunotherapy. Several computational methods have been developed for MSI detection using DNA- or RNA-based approaches based on next-generation sequencing. Epigenetic mechanisms, such as DNA methylation, regulate gene expression and play critical roles in the development and progression of cancer. We here developed MSI-XGNN, a new computational framework for predicting MSI status using bulk RNA-sequencing and DNA methylation data. MSI-XGNN is an explainable deep learning model that combines a graph neural network (GNN) model to extract features from the gene-methylation probe network with a CatBoost model to classify MSI status. MSI-XGNN, which requires tumor-only samples, exhibited comparable performance with two well-known methods that require tumor-normal paired sequencing data, MSIsensor and MANTIS and better performance than several other tools. MSI-XGNN also showed good generalizability on independent validation datasets. MSI-XGNN identified six MSI markers consisting of four methylation probes (EPM2AIP1|MLH1:cg14598950, EPM2AIP1|MLH1:cg27331401, LNP1:cg05428436 and TSC22D2:cg15048832) and two genes (RPL22L1 and MSH4) constituting the optimal feature subset. All six markers were significantly associated with beneficial tumor microenvironment characteristics for immunotherapy, such as tumor mutation burden, neoantigens and immune checkpoint molecules such as programmed cell death-1 and cytotoxic T-lymphocyte antigen-4. Overall, our study provides a powerful and explainable deep learning model for predicting MSI status and identifying MSI markers that can potentially be used for clinical MSI evaluation.